# A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)

> **NCT00140972** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 160 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** MK0663; etoricoxib / Duration of Treatment:4 Weeks
- **DRUG:** Comparator: diclofenac sodium tablet 75 mg / Duration of Treatment:4 Weeks

## Key facts

- **NCT ID:** NCT00140972
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12-03
- **Primary completion:** 2005-06-27
- **Final completion:** 2005-06-27
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140972, "A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00140972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*